JFL Life Sciences Limited

Aug 25, 2022 - Aug 30, 2022

---

Incorporated in 2010, JFL Life Sciences Limited is engaged in the business of manufacturing of pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).

The company's sales strategy is to sell the products in bulk to pharmaceutical marketers and traders who in turn provide the channel for sales to customers. JFL Life Sciences Limited has a market presence in PAN India and JFL's products are supplied to 10 developed and developing countries throughout the World.

JFL Life Sciences Limited exports products to African, Middle Eastern, and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing a particular product. Few of our products are also registered with Ukraine, Uzbekistan, and Kazakhstan (CIS countries) through merchants.

JFL has two manufacturing units (on lease) in Gujarat.

Competitive Strength :

1. Product registration
2. Experienced management and dedicated employee base
3. Quality assurance
4. Quality & Brand strength

Company Financials

JFL Life Sciences Limited Financial Information (Restated)

Period Ended	Total Assets	Total Revenue	Profit After Tax
31-Aug-19	1614.96	3177.96	30.25
31-Mar-20	2432.59	3020.41	36.04
31-Mar-21	2900.69	3286.89	54.21
28-Feb-22	3662.86	2563.06	253.28
Amount in ₹ Lakhs

KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: jfl.ipo@kfintech.com
Website: https://karisma.kfintech.com/